HeartSciences (HSCS) has secured a patent from the European Patent Office for its "Electrocardiogram-Based Assessment of Diastolic Function" technology, the healthcare information technology company said Thursday.
The patent, effective April 29, covers machine-learning models and methods that estimate echocardiogram parameters for diastolic function using patient data and provides coverage in 19 European countries, the company said.
Shares of HeartSciences were down 2.4% in early Thursday trading.
Price: 1.84, Change: -0.04, Percent Change: -2.39
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments